Accuray reported $39.52M in Gross Profit on Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbott ABT:US $ 6505M 1225M
Accuray ARAY:US $ 39.52M 4.21M
Atricure ATRC:US $ 52.23M 1.85M
Boston Scientific BSX:US $ 2018M 102M
Cardiovascular Systems CSII:US $ 44.06M 6.29M
Genmark Diagnostics GNMK:US $ 19.4M 2.86M
Hologic HOLX:US $ 828.1M 126.5M
Inogen INGN:US $ 47.69M 2.65M
Mesa Laboratories MLAB:US $ 23.14M 0.93M
Natus Medical BABY:US $ 67.65M 1.25M
Orthofix International OFIX:US $ 84.12M 9.83M
Oxford Immunotec Global OXFD:US $ 14.86M 11.19M
Surmodics SRDX:US $ 19.81M 1.04M
Tandem Diabetes Care TNDM:US $ 96.74M 4.29M
Trinity Biotech TRIB:US $ 8.9M 2.13M
Varian Medical Systems VAR:US $ 359M 15.7M